Bladder cancer

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that’s quickly establishing itself as the best of the best.  

A new poll, carried out by YouGov, has revealed that three quarters of the UK public think the NHS is understaffed and underequipped to tackle cancer

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

A new study is looking at how blood tests after cancer surgery can be used to select patients for additional treatment, potentially sparing some patients from unnecessary, often toxic, treatment whilst ensuring those who need it get it as early as possible.

The University of Birmingham has partnered with Nonacus, a company that develops non-invasive genetic testing devices, to produce a urine test for bladder cancer that could spare thousands of people invasive procedures.

We spoke to the team looking into the complex relationship between the gut microbiome and radiosensitisation in bladder cancer.


A treatment option for some people with bladder cancer, currently available through the CDF has been given an initial ‘no’ for routine use in England.

We speak to our scientists who are developing urine tests that aim to detect bladder and pancreatic cancer earlier.

Stopping smoking leaves postmenopausal women at a lower risk of bladder cancer than those who continue to smoke, new research confirms.

Women with bladder or kidney cancer may lose out on a prompt diagnosis if they are already being regularly treated for recurring urinary tract infections (UTIs)